Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
29 Novembro 2023 - 9:00AM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a
biopharmaceutical company focused on discovering, developing, and
commercializing important new medicines to improve the lives of
people with cancer, today announced that members of the management
team will participate in a virtual fireside chat at the JMP
Securities Hematology and Oncology Summit on Wednesday, December 6,
2023 at 1:30 PM ET.
A live webcast of the fireside chat will be available on the
“Events and Presentations” page in the “Investors” section of the
Company’s website at
https://investors.deciphera.com/events-presentations. A replay of
the webcast will be archived on the Company’s website for 90 days
following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing, and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
switch-control inhibitor for the treatment of fourth-line GIST.
QINLOCK is approved in Australia, Canada, China, the European
Union, Hong Kong, Israel, Macau, New Zealand, Singapore,
Switzerland, Taiwan, the United Kingdom, and the United States. For
more information, visit www.deciphera.com and follow us on LinkedIn
and X (@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231129967583/en/
Investor Relations: Maghan Meyers Argot Partners
Deciphera@argotpartners.com 212-600-1902
Media: David Rosen Argot Partners
david.rosen@argotpartners.com 212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024